drugset / Trial / NCT01295060
Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a long term study to evaluate the safety, tolerability and efficacy of an Octreotide Implant in patients that were previously treated with an Octreotide implant.
Timeline
- Start
- 2011-02
- Primary completion
- 2012-04
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Octreotide | Peptide | 84 mg | Subcutaneous |